Cancer
Researchers at the University of Cincinnati have developed a novel combination therapy for treating cancer metastases, which shows promise in addressing the long-standing challenge of treating the secondary growths that often accompany primary tumors. The therapy, which incorporates a combination of vascularization and/or tissue remodeling inhibitors, suppressors of oxidative
Cancer
The Endometrial Cancer market is experiencing significant growth due to the increasing prevalence and awareness of the disease. Emerging therapies and novel treatment strategies are also contributing to the market's expansion. According to a recent report by DelveInsight, the Endometrial Cancer market is expected to surge, with a
Cancer
Scientists at the Institute of National Importance have made significant advancements in cancer gene therapy with the development of nanoformulations of paclitaxel (PTX), a potent anticancer drug. These cutting-edge formulations aim to overcome the limitations of traditional PTX delivery, which is plagued by low aqueous solubility, limited oral bioavailability, and
Cancer
Research conducted by Chongqing University Cancer Hospital has shed light on the significant risk of thromboembolic events (TEEs) associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs). The study, published in Scientific Reports, analyzed data from the FAERS database and found that the incidence of TEEs was 2.
Cancer
The Renal Cancer pipeline landscape is thriving, with over 75 companies developing more than 80 pipeline therapies for the treatment of renal cell carcinoma (RCC). The pipeline is rich with innovative assets, including monoclonal antibodies, small molecules, and gene therapies, aimed at addressing the unmet needs of patients with this
Cancer
Researchers from the Chinese Academy of Sciences have made a groundbreaking discovery in the fight against cancer. By combining zinc phthalocyanines with polydopamine nanomaterials, they have created a dual photo synergistic therapy that exhibits potent antineoplastic effects and favorable biocompatibility. This innovative approach has shown significant promise in inhibiting tumor
Cancer
Researchers at Tel Aviv University have made a significant contribution to the field of personalized medicine, highlighting the impact of technological advancements on modern medicine. According to the study, the Human Genome Project has paved the way for a new age in medicine, enabling a deeper understanding of biological processes
Cancer
A new research study has been published in Molecular Imaging and Biology, outlining the steps for radiolabeling the antibody trastuzumab with zirconium-89 (89Zr) and copper-64 (64Cu) for positron emission tomography (PET) imaging. The study, conducted by researchers at Washington University, aims to provide a guide for conjugating trastuzumab with chelators
Cancer
Cancer researchers at China Medical University have made a significant breakthrough in the development of antibodies to target cancer cells expressing the CXC chemokine receptor 4 (CXCR4), a key player in various types of cancer. By employing the AlphaFold3 algorithm to predict interaction sites between ligands and GPCRs, the team
Cancer
Researchers at Southwest University have developed a groundbreaking nanomedicine that selectively kills cancer cells by depleting glutathione and generating hydroxyl radicals. This innovative approach, presented in a study published in the Journal of Colloid and Interface Science, offers a promising solution for enhanced chemodynamic cancer therapy. The nanoparticles, designed to
Cancer
A new study on endometrial cancer has found significant differences in the efficacy and safety of atezolizumab between Asian and non-Asian patients. The research analyzed data from the AtTEnd trial, a phase III double-blind randomized placebo-controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent
Cancer
The Oncolytic Virus Cancer Therapy pipeline has emerged as a significant area of focus for pharmaceutical companies, with over 120 key players actively working on developing therapies for the treatment of various cancer types. DelveInsight's report, "Oncolytic Virus Cancer Therapy Pipeline Insight, 2025," provides comprehensive insights
